We’ve recently updated our valuation analysis.

Henry Schein Valuation

Is HSIC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

[object Object] Score

5/6

Valuation Score 5/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for HSIC?

Other financial metrics that can be useful for relative valuation.

HSIC key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.1x
Enterprise Value/EBITDA12.5x
PEG Ratio3.7x

Price to Earnings Ratio vs Peers

How does HSIC's PE Ratio compare to its peers?

The above table shows the PE ratio for HSIC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average18.8x
ABC AmerisourceBergen
21.1x8.5%US$35.8b
PDCO Patterson Companies
14.3x6.5%US$2.8b
MCK McKesson
26.6x3.5%US$54.9b
OMI Owens & Minor
13.1x5.9%US$1.6b
HSIC Henry Schein
17.7x4.7%US$11.3b

Price-To-Earnings vs Peers: HSIC is good value based on its Price-To-Earnings Ratio (17.7x) compared to the peer average (18.8x).


Price to Earnings Ratio vs Industry

How does HSIC's PE Ratio compare vs other companies in the US Healthcare Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a14.4%
n/an/an/a

Price-To-Earnings vs Industry: HSIC is good value based on its Price-To-Earnings Ratio (17.7x) compared to the US Healthcare industry average (20.8x)


Price to Earnings Ratio vs Fair Ratio

What is HSIC's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

HSIC PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio17.7x
Fair PE Ratio21.6x

Price-To-Earnings vs Fair Ratio: HSIC is good value based on its Price-To-Earnings Ratio (17.7x) compared to the estimated Fair Price-To-Earnings Ratio (21.6x).


Share Price vs Fair Value

What is the Fair Price of HSIC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: HSIC ($83.29) is trading below our estimate of fair value ($109.16)

Significantly Below Fair Value: HSIC is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst HSIC forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$83.29
US$81.67
-1.9%
9.7%US$99.00US$71.00n/a12
Nov ’23US$71.74
US$82.33
+14.8%
9.2%US$99.00US$71.00n/a12
Oct ’23US$65.77
US$83.33
+26.7%
8.2%US$99.00US$72.00n/a12
Sep ’23US$72.69
US$84.25
+15.9%
9.1%US$99.00US$72.00n/a12
Aug ’23US$78.39
US$87.25
+11.3%
10.3%US$102.00US$72.00n/a12
Jul ’23US$77.11
US$88.25
+14.4%
10.3%US$102.00US$72.00n/a12
Jun ’23US$84.28
US$90.33
+7.2%
10.5%US$103.00US$72.00n/a12
May ’23US$81.10
US$90.42
+11.5%
10.7%US$103.00US$72.00n/a12
Apr ’23US$89.34
US$89.42
+0.09%
11.3%US$103.00US$72.00n/a12
Mar ’23US$86.31
US$89.42
+3.6%
11.3%US$103.00US$72.00n/a12
Feb ’23US$75.95
US$84.83
+11.7%
11.0%US$98.00US$67.00n/a12
Jan ’23US$77.53
US$85.91
+10.8%
10.0%US$98.00US$72.00n/a11
Dec ’22US$70.34
US$85.91
+22.1%
10.0%US$98.00US$72.00US$82.9511
Nov ’22US$76.65
US$83.91
+9.5%
10.1%US$95.00US$70.00US$71.7411
Oct ’22US$78.53
US$82.67
+5.3%
10.0%US$95.00US$68.00US$65.7712
Sep ’22US$76.66
US$83.85
+9.4%
10.7%US$98.00US$68.00US$72.6913
Aug ’22US$80.15
US$82.15
+2.5%
10.3%US$99.00US$68.00US$78.3913
Jul ’22US$75.51
US$82.07
+8.7%
11.6%US$99.00US$66.00US$77.1114
Jun ’22US$76.07
US$82.07
+7.9%
11.6%US$99.00US$66.00US$84.2814
May ’22US$72.50
US$73.57
+1.5%
11.5%US$93.00US$59.00US$81.1014
Apr ’22US$68.67
US$72.71
+5.9%
11.8%US$93.00US$59.00US$89.3414
Mar ’22US$64.55
US$72.40
+12.2%
11.6%US$93.00US$59.00US$86.3115
Feb ’22US$67.46
US$71.79
+6.4%
14.3%US$101.00US$59.00US$75.9514
Jan ’22US$66.86
US$70.60
+5.6%
11.1%US$90.00US$59.00US$77.5315
Dec ’21US$64.91
US$70.20
+8.1%
11.2%US$90.00US$59.00US$70.3415

Analyst Forecast: Target price is lower than the current share price.


Discover undervalued companies